Patents Assigned to Laboserve Pharmaceutical Company S.A.
  • ORAL SOLUTIONS COMPRISING LISDEXAMFETAMINE SALTS
    Publication number: 20210401781
    Abstract: Oral pharmaceutical solution comprising a pharmaceutically acceptable salt of lisdexamfetamine, and a pharmaceutically acceptable aqueous carrier comprising a buffer and a cosolvent selected from the group consisting of a glycol, a polyol, and a mixture thereof, wherein the pH of the solution is from 5.5 to 9.0. The oral pharmaceutical solution presents excellent physicochemical stability, even under alkaline conditions.
    Type: Application
    Filed: April 16, 2020
    Publication date: December 30, 2021
    Applicant: Laboserve Pharmaceutical Company S.A.
    Inventors: Georgios LIOLIOS, Ioannis PSARRAKIS